Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page
- Check4 days agoChange DetectedThe page updated from Revision v3.0.1 to v3.0.2; the 'Back to Top' link was removed. This appears to be a minor update with no evident changes to core content or key data.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated to include a new research article on the safety profile of Upadacitinib, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference1%
- Check18 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, while also removing several previous location entries. Notably, the names of cities and countries have been updated to reflect current terminology.SummaryDifference17%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.